PMC:7601109 / 715-1008 JSONTXT

Annnotations TAB JSON ListView MergeView

multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, and exercise mimetics) are being explored in different stages of trials, not a single drug has been approved for sarcopenia